180 related articles for article (PubMed ID: 10579080)
21. [Polychemotherapy using the M-VEC protocol (methotrexate, vinblastine, epirubicin, cisplatin) in advanced urinary bladder cancer--effectiveness and toxicity].
Rassweiler J; Rüther U; Bäuerle K; Bub P; Jipp P; Eisenberger F
Urologe A; 1989 Jan; 28(1):25-30. PubMed ID: 2922897
[TBL] [Abstract][Full Text] [Related]
22. Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group.
Malmström PU; Rintala E; Wahlqvist R; Hellström P; Hellsten S; Hannisdal E
J Urol; 1996 Jun; 155(6):1903-6. PubMed ID: 8618283
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group.
Splinter TA; Scher HI; Denis L; Bukowski R; Simon S; Klimberg I; Soloway M; Vogelzang NJ; van Tinteren H; Herr H
J Urol; 1992 Mar; 147(3):606-8. PubMed ID: 1538438
[TBL] [Abstract][Full Text] [Related]
24. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
Lehmann J; Franzaring L; Thüroff J; Wellek S; Stöckle M
BJU Int; 2006 Jan; 97(1):42-7. PubMed ID: 16336326
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant chemotherapy preceding cystectomy for bladder cancer.
Sonpavde G; Amiel GE; Mims MP; Hayes TG; Lerner SP
Expert Opin Pharmacother; 2008 Aug; 9(11):1885-93. PubMed ID: 18627327
[TBL] [Abstract][Full Text] [Related]
26. The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy.
Aparicio AM; Elkhouiery AB; Quinn DI
Urol Clin North Am; 2005 May; 32(2):217-30, vii. PubMed ID: 15862619
[TBL] [Abstract][Full Text] [Related]
27. Use of methotrexate, vinblastine, adriamycin, and cisplatin in combination with radiation and hyperthermia as neo-adjuvant therapy for bladder cancer.
Noguchi S; Kubota Y; Miura T; Shuin T; Hosaka M
Cancer Chemother Pharmacol; 1992; 30 Suppl():S63-5. PubMed ID: 1394821
[TBL] [Abstract][Full Text] [Related]
28. [Effectiveness of neoadjuvant chemotherapy for the patients with locally invasive bladder cancer].
Noguchi S; Takase K; Yoshida M; Yumura Y; Yamashita Y; Oogo Y; Miyoshi Y
Nihon Hinyokika Gakkai Zasshi; 2005 Jul; 96(5):548-53. PubMed ID: 16083032
[TBL] [Abstract][Full Text] [Related]
29. Transurethral resection in regionally advanced bladder cancer.
Herr HW
Urol Clin North Am; 1992 Nov; 19(4):695-700. PubMed ID: 1441026
[TBL] [Abstract][Full Text] [Related]
30. [The role of M-VAC polychemotherapy in the treatment of advanced urothelial carcinoma of the bladder].
Stöckle M; Meyenburg W; Wellek S; Voges G; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
Ann Urol (Paris); 1993; 27(1):51-7. PubMed ID: 7682388
[TBL] [Abstract][Full Text] [Related]
31. [Neoadjuvant chemotherapy with MVAC in bladder carcinoma: Is the feasibility really established? Of: Benadiba et al.: Neoadjuvant chemotherapy in muscular invasive bladder cancer: Complications and consequences on cystectomy, Pr Urol 2015; 25: 549-554].
Coquard R
Prog Urol; 2015 Dec; 25(16):1171-2. PubMed ID: 26420677
[No Abstract] [Full Text] [Related]
32. [Neoadjuvant chemotherapy in advanced-stage bladder carcinoma. A randomized prospective study comparing MVAC and MVEEC].
Monica B; Larosa M; Frattini A; Macaluso G; Cocconi G; Passalacqua R; Leonardi F
Arch Ital Urol Androl; 1994 Dec; 66(5):235-43. PubMed ID: 7812302
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant chemotherapy for bladder cancer.
Sonpavde G; Lerner SP
Oncology (Williston Park); 2007 Dec; 21(14):1673-81; discussion 1686-8, 1691, 1694. PubMed ID: 18247016
[TBL] [Abstract][Full Text] [Related]
34. [Adjuvant polychemotherapy after radical cystectomy of metastatic bladder cancer].
Stöckle M
Urologe A; 1994 Nov; 33(6):568-75. PubMed ID: 7817458
[TBL] [Abstract][Full Text] [Related]
35. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
Uekado Y; Ogawa T; Yoshida T; Yamamoto S; Hirano A; Watanabe T; Shinka T; Ohkawa T
Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemotherapy in transitional-cell carcinoma of the bladder.
McLaren DB
Clin Oncol (R Coll Radiol); 2005 Oct; 17(7):503-7. PubMed ID: 16238137
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant chemotherapy for non-organ confined bladder transitional cell carcinoma.
Abi-Aad AS
Acta Urol Belg; 1996 May; 64(2):35-7. PubMed ID: 8701808
[No Abstract] [Full Text] [Related]
38. Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
Pouessel D; Chevret S; Rolland F; Gravis G; Geoffrois L; Roubaud G; Terrisse S; Boyle H; Chevreau C; Dauba J; Moriceau G; Alexandre I; Deplanque G; Chapelle A; Vauleon E; Colau A; Audenet F; Grellety T; Culine S
Eur J Cancer; 2016 Feb; 54():69-74. PubMed ID: 26724422
[TBL] [Abstract][Full Text] [Related]
39. Combined chemotherapy and external beam radiotherapy for transitional cell carcinoma of the bladder.
Ennis RD
Curr Oncol Rep; 2004 May; 6(3):230-6. PubMed ID: 15066235
[TBL] [Abstract][Full Text] [Related]
40. Perioperative methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) for poor risk transitional cell carcinoma of the bladder: an Eastern Cooperative Oncology Group pilot study.
Dreicer R; Messing EM; Loehrer PJ; Trump DL
J Urol; 1990 Nov; 144(5):1123-6; discussion 1126-7. PubMed ID: 2231884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
